Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...

Recently announced positive data from pivotal randomized, placebo-controlled phase 3 clinical trial of CAN-2409 in intermediate-to-high risk, ...

intermediate-grade, and advanced prostate cancers. The study authors concluded that people considering a vasectomy should discuss the potential risk of prostate cancer with their doctor before ...

Last year was transformational for Candel, driven by our team’s incredible focus and execution of the Company’s key priorities,” said Paul ...

Veracyte VCYT shares have surged 45.6% in the past year, showing impressive momentum. It has significantly outperformed the industry’s 7.6% fall and the S&P 500 composite’s gain of 8.8%. Presently ...

SESAUA annual meeting featured a prostate cancer session and a presentation by Dr. Jamie Thomas discussing results from the MAST trial assessing the validation of PAM50 for predicting progression in ...

INmune Bio's high-upside potential with CORDStrom for RDEB and XPro for Alzheimer's, offering up to 144.8x returns. Click ...

Results from the NRG Oncology GOG-0263 phase III clinical trial testing the addition of cisplatin-based chemotherapy to adjuvant radiotherapy ...

Stock Market LIVE Updates | Indian equity indices Sensex and Nifty traded flat on Wednesday, as gains in metals, following ...

St Andrew’s Community Centre, 176 Cobden St. A Pop of Pink exhibition by Lindy McLachlan at Matawhero Art Gallery. Colourful, garden-themed paintings inspired by nature. 12pm-4pm at Matawhero Winery.

Ten Year Treatment Outcomes of Radical Prostatectomy vs External Beam Radiation Therapy vs Brachytherapy for 1,503 Patients with Intermediate Risk Prostate Cancer Comparison of definitive therapy of ...